Form 483

Oxygen Development, L.L.C. Form 483, 2013-11-22

FDA issued a Form 483 to Oxygen Development, L.L.C. on 2013-11-22 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Oxygen Development, L.L.C. · Palm Springs, United States · Issued November 22, 2013

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

22 Nov 2013
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Tamara J Henderson

22 Nov 2013
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Tamara J Henderson

22 Nov 2013
21 CFR 211.170(b)

Annual visual exams of drug products

Cited by Tamara J Henderson

Inspected site

ODOxygen Development, L.L.C.Palm Springs, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.170(b)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere